Taken together, the IF results confirmed that ΔCD24a 4T1 tumors exhibited an immune active phenotype, characterized by more abundant of tumor-suppressive immune cells including CD86+ M1 macrophages and cytotoxic CD8+ T cells compared to the pro-tumor immune suppressive phenotype of the 4T1 tumors. The gene discussed is CD86; the disease is neoplasm.